Skip to Content
Cancer Diagnosis Program (CDP) — Biorepositories & Biospecimen Research Branch (BBRB) Cancer Diagnosis Program (CDP) Biorepositories & Biospecimen Research Branch (BBRB)
Contact NExT
Show menu
Search this site
Last Updated: 09/01/17

The Genotype Tissue Expression (GTEx) Symposium: All Things Considered

The Genotype Tissue Expression (GTEx) Symposium: All Things Considered – Biospecimens, Omics Data, and Ethical Issues held at the National Institutes of Health May 20-21st, 2015 covered a broad range of topics that focused on the collection of normal biospecimens for GTEx. Topics included an overview of the GTEx program, the biospecimen challenges for GTEx, establishing the approach for GTEx prospective collections, new systems that were developed to implement the program, ethical, legal, and societal investigations within the program, and scientific outcomes from the GTEx Project thus far.

Both days of the GTEx Symposium can be viewed in full by clicking through the following links:

Day 1: http://videocast.nih.gov/Summary.asp?File=19024&bhcp=1
Day 2: http://videocast.nih.gov/Summary.asp?File=19026&bhcp=1

About GTEx:

The Genotype-Tissue Expression (GTEx) program is a National Institutes of Health (NIH) Common Fund study. The overall goal of the GTEx project is to increase our understanding of how changes in our genes contribute to common human disease to improve health care. To achieve that goal, GTEx collected and analyzed biospecimens from over 900 post-mortem donors. With over 800 cases of the total collection completed and analyzed to date, the GTEx program is making a significant impact on the understanding of human biology and how gene expression, gene mutation, and variation affect the development of disease.

For more information about the GTEx program, please visit: www.genome.gov/gtex